Fusion Family Wealth LLC Bristol Myers Squibb CO Transaction History

Fusion Family Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $90,079 - $98,096	-1,455 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $33,708 - $43,970	685 Added 88.96%	1,455 $93,000
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $21,598 - $25,608	-505 Reduced 39.61%	770 $39,000
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $22,533 - $24,916	505 Added 65.58%	1,275 $58,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $22,785 - $27,169	-505 Reduced 39.61%	770 $37,000
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $30,269 - $33,001	505 Added 65.58%	1,275 $78,000
Q3 2017 Oct 30, 2017	SELL	$55.23 - $63.74 $9,830 - $11,345	-178 Reduced 18.78%	770 $49,000
Q2 2017 Aug 07, 2017	BUY	N/A	948	948 $53,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fusion Family Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Fusion Family Wealth LLC with notifications on news.